Advanced and recurrent gynecological cancers are associated with poor prognosis and lack
of effective treatment. The developments of the molecular mechanisms on cancer …

Advanced-inoperable cervical cancer is a challenging entity due to increased percentage of
locoregional and distant recurrences. Furthermore, recurrent cervical cancer not amenable …

Purpose The KEYNOTE-028 trial (ClinicalTrials. gov identifier: NCT02054806) was
designed to assess the safety and efficacy of pembrolizumab in 20 programmed death …

Purpose Metastatic cervical cancer is a prototypical chemotherapy-refractory epithelial
malignancy for which better treatments are needed. Adoptive T-cell therapy (ACT) is …

Due to the generally poor prognosis of head and neck squamous cell carcinoma (HNSCC),
treatment has been intensified, these last decades, leading to an increase of serious side …

Cervical cancer is the fourth most common female cancer worldwide and results in over 300
000 deaths globally. The causative agent of cervical cancer is persistent infection with high …

Abstract Purpose of Review This review aims to summarize the current immunotherapy
studies and the potential targeted therapies showing promise in the treatment of cervical …

Despite screening programs for early detection and the approval of human papillomavirus
vaccines, around 6% of women with cervical cancer (CC) are discovered with primary …

Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women
throughout the world. Approximately two thirds of the patients are diagnosed with locally …

Background Cervical cancer is the fourth most common cancer affecting women worldwide.
Despite advances in screening and human papillomavirus (HPV) vaccination, a significant …